SCHEMBL19903833

SCHEMBL19903833

O=CNCCOC(=O)c1ccc(COc2cccc(C(NC=O)c3ccccc3)c2)cc1

nearest known ligand 0.45

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 7/20 0.45
SMN1; SMN2 Q16637 2/20 0.44
KMT2A Q03164 1/20 0.44
SPHK2 Q9NRA0 4/20 0.43
SPHK1 Q9NYA1 2/20 0.43
ADRB2 P07550 4/20 0.43
RXRA P19793 1/20 0.42
RXRB P28702 1/20 0.42
RXRG P48443 1/20 0.42
ADRB1 P08588 1/20 0.40
ADRB3 P13945 1/20 0.40
NR4A2 P43354 1/20 0.40
SMPD1 P17405 2/20 0.39
TSHR P16473 1/20 0.39
BCHE P06276 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15783775 0.74 CHRM3 (0.60) CHRM3SMN1; SMN2KMT2ASPHK2SPHK1
SCHEMBL19984510 0.73 CHRM3 (0.64) CHRM3SMN1; SMN2KMT2ASPHK2SPHK1
SCHEMBL19903889 0.73 CHRM3 (0.43) CHRM3KMT2AADRB2RXRARXRB
SCHEMBL19984492 0.73 CHRM3 (0.42) CHRM3SMN1; SMN2KMT2ABCHE
SCHEMBL14241401 0.72 CHRM3 (0.46) CHRM3SMN1; SMN2KMT2ASPHK2SPHK1
SCHEMBL28850003 0.72 TDP1 (0.59) SMN1; SMN2KMT2AADRB2ADRB1ADRB3
SCHEMBL20373866 0.71 CHRM3 (0.62) CHRM3SMN1; SMN2KMT2ASPHK2SPHK1
SCHEMBL19984677 0.71 RXRA (0.57) CHRM3SMN1; SMN2KMT2ASPHK2SPHK1
SCHEMBL19984429 0.71 CHRM3 (0.62) CHRM3SMN1; SMN2KMT2ASPHK2SPHK1
SCHEMBL3443226 0.71 KMT2A (0.53) SMN1; SMN2KMT2AADRB2ADRB3NR4A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2928890-B1 COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY CHIESI FARM SPA (IT) 2018-02-28 EP disclosed